Donald Trump’s pick to lead the federal health agency has vowed to replace hundreds of staffers and shift research away from infectious diseases and vaccines. Such an overhaul could imperil the development of life-saving treatments,

The past three administrations have tried to limit gain-of-function research. The second Trump administration might be the first one to be successful at doing so.

President Trump stormed into the White House with a whirlwind of a first week, quickly making good on a number of campaign promises while embracing the trappings of the presidency. Trump’s first full week of his second term saw him sign dozens of executive orders,

President Donald Trump has ended the federal security detail for Dr. Anthony Fauci, the infectious disease expert who advised him on the COVID-19 pandemic.

President Joe Biden granted pardons to several prominent public servants Monday who have faced attacks from President-elect Donald Trump in one of his final acts in office.

For decades, researchers with funding from the NIH’s National Institute of Allergy and Infectious Diseases have labored ... Straight, white men are still overrepresented in clinical research ...

The heads of the Jan. 6 committee say they're grateful for the decision by President Joe Biden to pardon them “not for breaking the law but for upholding it.” The

President Donald Trump had his first official interview in the Oval Office Wednesday and reflected on his return to the

Biden, Jr., President of the United States, pursuant to my powers under Article II, Section 2, Clause 1, of the Constitution, have granted unto Dr. Anthony S. Fauci A Full and Unconditional Pardon For any offenses against the United States which he may have committed or taken part in during the period from January 1,

These and other major medical breakthroughs exist in large part thanks to a major division of the National Institutes of Health, the largest funder of biomedical research on the planet.

The newly sworn-in president’s retribution tour has already begun, starting with his former officials who hurt his feelings

Dr. Matthew Memoli, a National Institute of Allergy and Infectious Diseases researcher focused on flu and other respiratory viruses, has been named acting director of the nearly $50 billion agency.